肌肉减少与胰岛素抵抗及骨密度的相关性研究

晨 杨(承德医学院附属医院，中国)
桂艳 韩(承德医学院附属医院，中国)

摘要

bone mineral density

关键词

甘油三酯葡萄糖指数；骨骼肌质量指数；肌少症；骨密度

参考

Chen L K, Liu L K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J]. Journal of the American Medical Directors Association, 2014, 15(2): 95-101.

Cruz-Jentoft A J, Baeyens J P, Bauer J M, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People[J]. Age and ageing, 2010, 39(4): 412-423.

Kitamura A, Seino S, Abe T, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults[J]. Journal of cachexia, sarcopenia and muscle, 2021, 12(1): 30-38.

Rubio-Ruiz M E, Guarner-Lans V, Pérez-Torres I, et al. Mechanisms underlying metabolic syndrome-related sarcopenia and possible therapeutic measures[J]. International journal of molecular sciences, 2019, 20(3): 647.

Li C, Yu K, Shyh‐Chang N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review[J]. Journal of cachexia, sarcopenia and muscle, 2022, 13(2): 781-794.

Srikanthan P, Karlamangla A S. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey[J]. The Journal of Clinical Endocrinology & Metabolism, 2011, 96(9): 2898-2903.

Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride-glucose index, a predictor of type 2 diabetes development: a retrospective cohort study[J]. Primary care diabetes, 2020, 14(2): 161-167.

Ahn S H, Lee J H, Lee J W. Inverse association between triglyceride glucose index and muscle mass in Korean adults: 2008–2011 KNHANES[J]. Lipids in Health and Disease, 2020, 19: 1-9.

National Institutes of Health. “Osteoporosis prevention, diagnosis, and therapy.”NIH consensus statement 17.1 (2000): 1-36.

Gao, Qianqian, et al. “Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis.”Nutrients 13.12 (2021): 4291.

Shevroja, Enisa, et al. “DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis.”Endocrine 74 (2021): 20-28.

Clynes, Michael A., et al. “Osteosarcopenia: where osteoporosis and sarcopenia collide.”Rheumatology 60.2 (2021): 529-537.

Baczek, Jan, Marta Silkiewicz, and Zyta Beata Wojszel. “Myostatin as a biomarker of muscle wasting and other pathologies-state of the art and knowledge gaps.” Nutrients 12.8 (2020): 2401.

Kim B, Kim G, Lee Y, et al. Triglyceride–glucose index as a potential indicator of sarcopenic obesity in older people[J]. Nutrients, 2023, 15(3): 555.

Tahapary, Dicky Levenus, et al. “Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride/glucose index.” Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16.8 (2022): 102581.

Mezza T, Cinti F, Cefalo C M A, et al. β-cell fate in human insulin resistance and type 2 diabetes: a perspective on islet plasticity[J]. Diabetes, 2019, 68(6): 1121-1129.

Abdulla H, Smith K, Atherton P J, et al. Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis[J]. Diabetologia, 2016, 59(1): 44-55.

Chen, Yong, Chongwu Liu, and Mingdong Hu. “Association between triglyceride-glucose index and sarcopenia in China: a nationally representative cohort study.” Experimental Gerontology 190 (2024): 112419.

Li, Min, et al. “Higher triglyceride-glucose index and triglyceride glucose-body mass index protect against sarcopenia in Chinese middle-aged and older non-diabetic women: a cross-sectional study.” Frontiers in Public Health 12 (2025): 1475330.

Ahn, Sung-Ho, Jun-Hyuk Lee, and Ji-Won Lee. “Inverse association between triglyceride glucose index and muscle mass in Korean adults: 2008–2011 KNHANES.” Lipids in Health and Disease 19 (2020): 1-9.

Lee K .Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance[J].Journal of Bone and Mineral Metabolism:1-7[2024-09-21].DOI:10.1007/s00774-020-01104-2.

Li G B, Zhang L, Wang D E, et al. Muscle‐bone crosstalk and potential therapies for sarco‐osteoporosis[J]. Journal of cellular biochemistry, 2019, 120(9): 14262-14273.

Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism[J]. Cell, 2010, 142(2): 296-308.

Napoli N, Conte C, Pedone C, et al. Effect of insulin resistance on BMD and fracture risk in older adults[J]. The Journal of Clinical Endocrinology & Metabolism, 2019, 104(8): 3303-3310.

He, Yong, et al. “High serum AST/ALT ratio and low serum INS PA product are risk factors and can diagnose sarcopenia in middle-aged and older adults.” Frontiers in endocrinology 13 (2022): 843610.

Jiang, Yiwen, et al. “The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study.” Scientific Reports 13.1 (2023): 17538.

Wang R, Wang Y, Wei Z, et al. The association between HDL-c levels and computed tomography-based osteosarcopenia in older adults[J]. BMC Musculoskeletal Disorders, 2024, 25(1): 932.

Hussain S M, Ebeling P R, Barker A L, et al. Association of plasma high-density lipoprotein cholesterol level with risk of fractures in healthy older adults[J]. JAMA cardiology, 2023, 8(3): 268-272.

Liu C, Dhindsa D, Almuwaqqat Z, et al. Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations[J]. JAMA cardiology, 2022, 7(7): 672-680.

Ahmed B, Sultana R, Greene M W. Adipose tissue and insulin resistance in obese[J]. Biomedicine & pharmacotherapy, 2021, 137: 111315.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v9i1.35848